Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis
NCT05337891 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-10-10
Summary
Myasthenia gravis (MG) is the autoimmune disorder affecting the neuromuscular junction, characterized by fatigue, which increases gradually through the day. The repetitive nerve stimulation (RNS) remains the key diagnostic test in MG, however its sensitivity, especially in ocular form of MG is not satisfactory. In this study, investigators want to assess the impact of the time of the day on the sensitivity of the RNS. We hypothesize the RNS performed in the evening may be more sensitive than in the morning.
Conditions
Sponsors & Collaborators
-
Jagiellonian University
lead OTHER
Principal Investigators
-
Jakub M Antczak, MD · Jagiellonian University Medical College, Department of Neurology
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-03
- Primary Completion
- 2026-05-01
- Completion
- 2026-09-01
Countries
- Poland
Study Locations
More Related Trials
-
Immune Profiles in Myasthenia Gravis
NCT05095103 ·Status: UNKNOWN
-
Clinical and Laboratory Profile of Myasthenia Gravis in Children At Sohag University Hospitals
NCT06774937 ·Status: NOT_YET_RECRUITING
-
Markers of Favorable Response to FcRn Inhibitors(INFORM)
NCT06685055 ·Status: RECRUITING
-
Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
NCT02565576 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
NCT05214612 ·Status: RECRUITING
-
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
NCT06381284 ·Status: COMPLETED
-
Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test
NCT03905161 ·Status: COMPLETED
-
Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients
NCT05311904 ·Status: COMPLETED
-
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
NCT05332587 ·Status: UNKNOWN ·Phase: PHASE3
-
Interleukin and Autoantibodies in Myasthenia Gravis.
NCT05301153 ·Status: UNKNOWN
-
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
NCT06877403 ·Status: ENROLLING_BY_INVITATION
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
NCT07071246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab
NCT07337395 ·Status: NOT_YET_RECRUITING
-
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Repetitive Transorbital Alternating Current Stimulation in Acute Autoimmune Optic Neuritis
NCT03862313 ·Status: TERMINATED ·Phase: NA
-
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
NCT07247279 ·Status: RECRUITING
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Myasthenia Gravis Registry in China
NCT06241521 ·Status: RECRUITING
-
Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)
NCT06965309 ·Status: TERMINATED ·Phase: NA
-
Digital Phenotyping and Lifestyle Intervention in Patients with Myasthenia Gravis
NCT05992025 ·Status: COMPLETED ·Phase: NA
-
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT03751644 ·Status: COMPLETED ·Phase: NA
-
Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
NCT03597373 ·Status: UNKNOWN
-
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
NCT00727194 ·Status: TERMINATED ·Phase: PHASE2